Risk of Ventricular Proarrhythmia with Selective Opening of the Myocardial Sarcolemmal versus Mitochondrial ATP-Gated Potassium Channel

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 554-559

  Fischbach, Peter S ^a   White, Andrew ^a   Barrett, Terrance D ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 CHLOROPHENYL) N (1H IMIDAZOL 2 YLMETHYL)DIMETHYL 2H 1 BENZOPYRAN 6 CARBONITRIL MONOHYDROCHLORIDE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; BMS 191095; CLAMIKALANT; PINACIDIL; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADENOSINE TRIPHOSPHATE GATED POTASSIUM CHANNEL; ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG ANTAGONISM; HEART ARRHYTHMIA; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; REOXYGENATION; SARCOLEMMA; SIGNAL TRANSDUCTION;

ANIMALS; ANOXIA; ARRHYTHMIA; BENZOPYRANS; HEART; IMIDAZOLES; MALE; MEMBRANE PROTEINS; MITOCHONDRIA, HEART; MYOCARDIUM; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RABBITS; SARCOLEMMA;

EID: 2142697182     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060780     Document Type: Article

References (34)

1. Billman GE (1994) Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia. Cardiovasc Res 28:762-769.
2. Billman GE, Avendano CE, Halliwill JR, and Burroughs JM (1993) The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J Cardiovasc Pharmacol 21:197-204.
3. Billman GE, Englert HC, and Scholkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286:1465-1473.
4. Bugge E and Ytrehus K (1996) Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. Cardiovasc Res 32:920-929.
5. Cason BA, Gamperl AK, Slocum RE, and Hickey RF (1997) Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 87:1182-1190.
6. Chi L, Black SC, Kuo PI, Fagbemi SO, and Lucchesi BR (1993) Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel. J Cardiovasc Pharmacol 21:179-190.
7. Chi L, Uprichard AC, and Lucchesi BR (1990) Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 15:452-464.
8. Cohen MV, Yang XM, Liu GS, Heusch G, and Downey JM (2001) Acetylcholine, bradykinin, opioids and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 89:273-278.
9. Conrad CH, Mark RG, and Bing OH (1983) Outward current and repolarization in hypoxic rat myocardium. Am J Physiol 244:H341-H350.
10. Cope DK, Impastato WK, Cohen MV, and Downey JM (1997) Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 86:699-709.
11. Fischbach PS, Barrett TD, Reed NJ, and Lucchesi BR (2003) SNC-80-induced pre-conditioning: selective activation of the mitochondrial adenosine triphosphategated potassium channel. J Cardiovasc Pharmacol 41:744-750.
12. Flagg TP and Nichols CG (2001) Sarcolemmal K(ATP) channels in the heart: molecular mechanisms brought to light, but physiologic consequences still in the dark. J Cardiovasc Electrophysiol 12:1195-1198.
13. Friedrichs GS, Abreu JN, Black SC, Chi L, and Lucchesi BR (1996a) 5-Hydroxyde-canoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death. Eur J Pharmacol 306:99-106.
14. Friedrichs GS, Abreu JN, Cousins GR, Chi L, Borlak J, and Lucchesi BR (1996b) Tedisamil attenuates ventricular fibrillation in a conscious canine model of sudden cardiac death. J Cardiovasc Pharmacol Ther 1:313-324.
15. Friedrichs GS, Abreu JN, Driscoll EM Jr, Borlak J, and Lucchesi BR (1998) Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation. J Cardiovasc Pharmacol 31:56-66.
16. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, and Grover GJ (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81:1072-1082.
17. Gribble FM, Reimann F, Ashfield R, and Ashcroft FM (2000) Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A. Mol Pharmacol 57:1256-1261.
18. Gwilt M, Henderson CG, Orme J, and Rourke JD (1992) Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro. Eur J Pharmacol 220:231-236.
19. Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, and Seino S (1996) A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16:1011-1017.
20. Inagaki N, Gonoi T, Clement JPt, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, and Bryan J (1995) Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science (Wash DC) 270:1166-1170.
21. Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, and Opie LH (1990) Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res 66:478-485.
22. Kersten JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ, and Warltier DC (1996) Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 85:794-807; discussion 727A.
23. Liang BT and Gross GJ (1999) Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 84:1396-1400.
24. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, and Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350-356.
25. Liu Y, Sato T, O'Rourke B, and Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97:2463-2469.
26. Murry CE, Jennings RB, and Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
27. Nakano A, Cohen MV, and Downey JM (2000) Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther 86:263-275.
28. Noma A (1983) ATP-regulated K+ channels in cardiac muscle. Nature (Lond) 305: 147-148.
29. Oldenburg O, Cohen MV, Yellon DM, and Downey JM (2002) Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res 55:429-437.
30. Schultz JE and Gross GJ (2001) Opioids and cardioprotection. Pharmacol Ther 89:123-137.
31. Smallwood JK, Ertel PJ, and Steinberg MI (1990) Modification by glibenclamide of the electrophysiological consequences of myocardial ischaemia in dogs and rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 342:214-220.
32. Wall TM, Sheehy R, and Hartman JC (1994) Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270:681-689.
33. Wang P, Gallagher KP, Downey JM, and Cohen MV (1996) Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 28:579-588.
34. Wolleben CD, Sanguinetti MC, and Siegl PK (1989) Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol 21:783-788.